CD4 Lymphocyte CountAntigens, CD8Antigens, CD3CD4-CD8 RatioCD40 LigandHIV InfectionsAntigens, CD40Antigens, CD44Antiretroviral Therapy, Highly ActiveAntigens, CD34Antigens, CD28Anti-HIV AgentsViral LoadCD4-Positive T-LymphocytesAntigens, CD14Antigens, CD38Anti-Retroviral AgentsAntigens, CD1Antigens, CD80HIV-1Antigens, CD2Antigens, CD19Antigens, CD86NevirapineAntigens, CD95Antigens, CD5Antigens, CDAntigens, CD18Antigens, CD56South AfricaAntigens, CD30Antigens, CD24Antigens, CD36Antigens, CD9Cohort StudiesAntigens, CD20Antigens, CD7Antigens, CD43CD8-Positive T-LymphocytesTreatment OutcomeAntigens, CD11BotswanaAntigens, CD47Antigens, CD59Antigens, CD70Antigens, CD46Antigens, CD11bAcquired Immunodeficiency SyndromeAntigens, CD57HIVTime FactorsAntigens, CD81AIDS-Related Opportunistic InfectionsRNA, ViralBenzoxazinesAntigens, CD137Follow-Up StudiesCD30 LigandAntigens, CD31Antigens, CD11cDrug Therapy, CombinationAntigens, CD151Antigens, CD55Antigens, CD58Lost to Follow-UpStavudineProspective StudiesDrug Administration ScheduleAntigens, CD63Disease ProgressionAntigens, CD13RitonavirAntigens, CD11aUgandaIndinavirRetrospective StudiesHIV Protease InhibitorsLongitudinal StudiesReverse Transcriptase InhibitorsLopinavirImmunophenotypingViremiaAntigens, CD147Risk FactorsAntigens, CD82Treatment FailureTuberculosisHIV SeropositivityLamivudineProportional Hazards ModelsZidovudineAntigens, CD274Antigens, CD146Multivariate AnalysisMedication AdherenceImmunologic MemoryFlow CytometryDendritic CellsIncidenceAntigens, Differentiation, T-Lymphocyte